European Commission extends approval for daratumumab to include pretreated multiple myeloma

The European Commission (EC) has granted approval to daratumumab for use in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma (MM) who have received at least one...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qoAt8X
via IFTTT